In another study by Yang et al. (2015), PRMT5 levels were found to be up‐regulated in various breast cancer cells including MCF7, MDA‐MB‐231, MCF‐10A and clinical samples of ductal carcinoma, and that its expression is positively associated with enhanced mortality.25 Here, PRMT5 is linked to breast ductal adenocarcinoma.